Metraipolis › archive › dc_5bb5b531c4fa

Impact of COVID-19 therapeutics on the development of post-infectious lung fibrosis — Europe PMC PMID:41277954

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41277954
DOI
10.3389/fmicb.2025.1677734
License (as archived)
solo-consultazione
Archived
2026-11-08T18:29:08.169Z
SHA-256 of the archived text
136362df83ed2231297984caef550aeb94a926d514dc116e0eed6cdb163323bd
Stable URL of this page
https://metraipolis.com/documento/dc_5bb5b531c4fa

How to cite

Impact of COVID-19 therapeutics on the development of post-infectious lung fibrosis — Europe PMC PMID:41277954 — Europe PMC (en), https://europepmc.org/article/MED/41277954 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5bb5b531c4fa (Metraipolis archive dc_5bb5b531c4fa, sha256 136362df83ed2231297984caef550aeb94a926d514dc116e0eed6cdb163323bd)
BibTeX
@misc{dc5bb5b531c4fa,
  title = {Impact of COVID-19 therapeutics on the development of post-infectious lung fibrosis — Europe PMC PMID:41277954},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41277954},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5bb5b531c4fa; sha256 136362df83ed2231297984caef550aeb94a926d514dc116e0eed6cdb163323bd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41277954. Agents can read the archived copy with the MCP tool read_document.